logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12714711 B1

PDFFull Text
Date of Patent:
Aug. 25, 2026

Filed:

May. 05, 2021

Salts of neuroceuticals and uses thereof

Applicant:

Syneurx International (Taiwan) Corp., New Taipei City, TW;

Inventors:

Guochuan Emil Tsai, Pasadena, CA (US);

Ching-Cheng Wang, New Taipei City, TW;

Tien-Lan Hsieh, New Taipei City, TW;

Yi-Feng Huang, New Taipei City, TW;

Hsin-Hsin Yang, New Taipei City, TW;

Ming-Hong Chien, New Taipei City, TW;

Han-Yi Hsieh, New Taipei City, TW;

Wei-Hua Chang, New Taipei City, TW;

Assignee:

SYNEURX INTERNATIONAL (TAIWAN) CORP.;

Attorney:

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Alexander K. Showalter

Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/195 (2006.01); A61K 31/455 (2006.01); A61K 31/496 (2006.01); A61K 31/551 (2006.01); A61K 31/5513 (2006.01); A61K 31/554 (2006.01); A61K 45/06 (2006.01); A61P 3/10 (2006.01); A61P 25/00 (2006.01); A61P 25/18 (2006.01); C07D 213/80 (2006.01); C07D 243/38 (2006.01); C07D 281/16 (2006.01); C07D 309/10 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 493/04 (2006.01); C07D 495/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/195 (2013.01); A61K 31/5513 (2013.01); A61K 31/554 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01); A61P 25/18 (2018.01); C07B 2200/13 (2013.01);
Abstract

A salt of a neuroceutical and of an acid, wherein the neuroceutical is a substituted benzodiazepine, a substituted benzothiazepine, a substituted pyridopyrimidines or a substituted amino-cyclohexaneacetic acid; and the acid is benzoic acid, nicotinic acid, pantothenic acid and tannic acid. The molar ratio of the neuroceutical and the acid in the salt ranges from about 6:1 to about 1:5. Also disclosed herein are compositions comprising the neuroceutical salt and therapeutic uses thereof for treating a central nervous system (CNS) disorder or a metabolic disorder associated with the CNS disorder.

Find Patent Forward Citations

Tsai, Guochuan. (2026). Salts of neuroceuticals and uses thereof (U.S. Patent No. 12714711). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12714711

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…